Αρχική World News News digest – calorie guidelines, reduced lung cancer referrals and COVID-19’s impact...

News digest – calorie guidelines, reduced lung cancer referrals and COVID-19’s impact on cancer services

Image was taken before the coronavirus pandemic.

Urgent lung cancer referrals down during lockdown

Of all cancer types, those with suspected lung cancer were the least likely to receive an urgent referral during lockdown, it has emerged. At the end of August, the number of people being sent for urgent tests was still only at 60% of pre-lockdown levels. Reasons for the reduced referral rates include fewer patients going to their GPs with coughs or breathing problems, and difficulties getting chest X-rays for patients during the pandemic. The Sun and our news report has more.

Childhood cancer survivor now works as a researcher on Cancer Research UK-funded trials

Diagnosed with leukaemia at 14, Catherine Pointer was inspired to become a scientist by one of her consultants. Now with a PhD in cancer research, she’s working on a Cancer Research UK-funded clinical trial and iscommitted to finding new treatment options for people with cancer. As reported in The Guardian, she said: “I want to see the day that children and young people going through cancer can come through the other side and be able to live well, not just survive with a lifetime of side effects from the treatment they had.”

We’ve recently written about children’s cancer on the blog as part of Childhood Cancer Awareness Month during September.

Food industry encouraged to cut excessive calories by 2024

Public Health England have published new voluntary calorie-reduction guidelines to help tackle obesity in the UK. Alongside salt reduction targets, Government advice will encourage the food industry to cut calories in unhealthy products by up to 20%. The guidelines focus specifically on meal options for eating out, takeaway and delivery, with research suggesting people consume an average of 200 more calories a day when eating meals they have not prepared themselves.

Blood test could help guide breast cancer treatment

The test can identify a variety of rare mutations in advanced breast cancer, allowing doctors to match patients with targeted treatments. This could also eliminate the need for invasive biopsies. Researchers say the test is now reliable enough to be offered to patients and is currently awaiting approval for routine use. The Times and our press release has the story.

Latest NHS drug decisions

  • A myeloma maintenance treatment received an initial rejection for NHS use in England. More in our news report
  • A targeted drug for lung cancer has been approved for NHS use in England. Our news report has the details of the decision.

And finally…

Six months after the UK entered lockdown, we now have a clearer picture of how COVID-19 has affected cancer services. Reduced screening and delays in diagnosis and referral are just some of the trends seen over the course of pandemic. The number of patients starting cancer treatment in England also dropped during lockdown. However, data now shows cancer services are beginning to get back on track. Get the full breakdown on our blog.

Scarlett Sangster is a writer for PA Media Group

More on this topic



Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...


Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...


ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

Making Important Decisions During Cancer: A Survivor’s Story

Bethany Hart lives with her husband Kevin, sons, and 3 dogs in the suburbs of Indianapolis, Indiana. She is a survivor of small cell neuroendocrine cervical cancer....

Adjuvant Immunotherapy Approved for Some Patients with Lung Cancer

October 26, 2021, by NCI Staff Atezolizumab (Tecentriq) is approved as an additional treatment for some patients with stage II to IIIA (pictured) non-small cell...

Cure Probability Models for Evaluation of Patients with a Previous Cancer Diagnosis for Solid Organ Transplantation

Findings from a first study that applied a formal statistical framework to inform the evaluation of transplant candidates with a previous cancer diagnosis were...

Teacher Reads To Students One Day After Having Brain Surgery

Meucci - who had her surgery on a Wednesday - was going live from her intensive care unit hospital room that very next Thursday...

6 things you need to know about cervical screening

This article was originally published in 2017 during Cervical Screening Awareness Week. It has now been reviewed and updated. Cervical screening, also known as the...

EMA Recommends Granting a Marketing Authorisation for Sacituzumab Govitecan

On 14 October 2021, the European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting...